New standards needed for radiation therapy

February 26, 2008

Modern radiation techniques result in substantial variation between the prescribed dose and the actual dose of radiation delivered to the tumor, according to a study published online February 26 in the Journal of the National Cancer Institute. As a result of this newly uncovered trend, the authors are calling for national guidelines for intensity-modulated radiation therapy (IMRT).

IMRT systems are designed to deliver the prescribed dose of radiation to a tumor while sparing surrounding tissues. IMRT does this by delivering many small beams of radiation that are individually controlled. Because of the complexity of the system, radiation oncologists and physicists rely on special software and equipment to deliver the planned dose over the treatment area.

In the current study, Indra J. Das, Ph.D., and colleagues at the University of Pennsylvania in Philadelphia reviewed the data for 803 patients who were treated with IMRT for brain, prostate, or head and neck cancer at one of five institutions between October 2004 and July 2006. The researchers determined the minimum, maximum, and median radiation doses delivered over the targeted region by using the planned dose for each patient and measuring the actual amount of radiation in plastic or water that radiologically resembles tissue.

By comparing the measured dose to the planned dose, the investigators discovered that 369 patients (46 percent) received a maximum dose delivered to some portion of the tissue that was more than 10 percent above the prescribed dose. (Ten percent is the typically acceptable level of variation.) Moreover, the minimum dose delivered to the tumor site in 506 patients (63 percent) was more than 10 percent below the prescribed dose.

"We found that in IMRT the prescribed dose rarely corresponded to the planned, or delivered, dose," the authors write. "Dosimetric variations between the prescribed dose and the recorded dose could be reduced by establishing international and/or national guidelines."

In an accompanying editorial, John Willins, Ph.D., and Lisa Kachnic, M.D., of the department of radiation oncology at Boston Medical Center and Massachusetts General Hospital commend the authors for putting together an important dataset that provides a new window into the clinical application of IMRT.

The editorialists endorse the authors' call for guidelines in IMRT. "Widespread use of IMRT planning standards would not only facilitate multicenter clinical trials but would also provide clinicians with solid guidance in their everyday practice on the question of what constitutes a 'good' IMRT plan," they write.
Article: Olivia Fermano,, (215) 349-5653
Editorial: John Willins,, (617) 638-7192

Note to Reporters:

We have started up an e-mail list to alert reporters when papers are available on the EurekAlert site. If you would be interested on being on this list, please let us know at The content will continue to be available through EurekAlert's e-mail system and our EurekAlert page.

The Journal of the National Cancer Institute is published by Oxford University Press and is not affiliated with the National Cancer Institute. Attribution to the Journal of the National Cancer Institute is requested in all news coverage. Visit the Journal online at

Journal of the National Cancer Institute

Related Radiation Articles from Brightsurf:

Sheer protection from electromagnetic radiation
A printable ink that is both conductive and transparent can also block radio waves.

What membrane can do in dealing with radiation
USTC recently found that polymethylmethacrylate (PMMA) and polyvinyl chloride (PVC) can release acidic substance under γ radiation, whose amount is proportional to the radiation intensity.

First measurements of radiation levels on the moon
In the current issue (25 September) of the prestigious journal Science Advances, Chinese and German scientists report for the first time on time-resolved measurements of the radiation on the moon.

New biomaterial could shield against harmful radiation
Northwestern University researchers have synthesized a new form of melanin enriched with selenium.

A new way to monitor cancer radiation therapy doses
More than half of all cancer patients undergo radiation therapy and the dose is critical.

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer
Oncotarget Volume 11, Issue 4: In this study, locally advanced head and neck cancer patients undergoing definitive chemoradiation were randomly allocated to weekly cisplatin - radiation {CRT arm} or nimotuzumab -weekly cisplatin -radiation {NCRT arm}.

Breaking up amino acids with radiation
A new experimental and theoretical study published in EPJ D has shown how the ions formed when electrons collide with one amino acid, glutamine, differ according to the energy of the colliding electrons.

Radiation breaks connections in the brain
One of the potentially life-altering side effects that patients experience after cranial radiotherapy for brain cancer is cognitive impairment.

Fragmenting ions and radiation sensitizers
The anti-cancer drug 5-fluorouracil (5FU) acts as a radiosensitizer: it is rapidly taken up into the DNA of cancer cells, making the cells more sensitive to radiotherapy.

'Seeing the light' behind radiation therapy
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime.

Read More: Radiation News and Radiation Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to